Pharma money powers Mumbai’s luxury market, Blue Jet promoter snaps up ₹202-cr apartments

Akshay Bansarilal Arora, promoter of Blue Jet Healthcare, acquired two units in the super-luxury skyscraper Palais Royale from Honest Shelters Pvt Ltd.

By  Storyboard18Aug 12, 2025 11:39 AM
Pharma money powers Mumbai’s luxury market, Blue Jet promoter snaps up ₹202-cr apartments
Worli has emerged as a prime luxury real estate hotspot alongside South Mumbai, Lower Parel, Prabhadevi, and Bandra, with several projects crossing the ₹1 lakh per sq ft mark.

Mumbai’s Worli continues to attract big-ticket deals from India’s pharmaceutical elite, with the promoter family of Blue Jet Healthcare purchasing three luxury apartments worth over ₹202 crore, property registration documents accessed by Zapkey show.

Akshay Bansarilal Arora, promoter of Blue Jet Healthcare, acquired two units in the super-luxury skyscraper Palais Royale from Honest Shelters Pvt Ltd. Each 7,669 sq ft apartment, priced at ₹57.14 crore, comes with five car parking spaces.

In a separate transaction, Shiven Akshay Arora purchased a 7,747 sq ft residence in Raheja Artesia, Worli, for ₹88 crore. The apartment includes six parking spaces.

Worli has emerged as a prime luxury real estate hotspot alongside South Mumbai, Lower Parel, Prabhadevi, and Bandra, with several projects crossing the ₹1 lakh per sq ft mark.

The pharma sector’s interest in high-end housing has been evident in recent months. In one of India’s largest-ever residential deals, USV chairperson Leena Gandhi Tewari bought two luxury sea-facing duplexes in Worli for ₹639 crore, paying an additional ₹63.9 crore in stamp duty and GST—bringing the total transaction value to about ₹703 crore.

Earlier this year, the Zydus Family Trust, linked to Zydus Lifesciences Ltd, acquired a ₹200-crore luxury apartment in the same locality, while last year Vibha Shanghvi, wife of Sun Pharma chief Dilip Shanghvi, purchased two Worli apartments for ₹130 crore.

Industry experts say such deals reflect a post-pandemic wealth surge in the pharmaceutical industry, with high-end properties seen as both secure investments and symbols of status.

First Published on Aug 12, 2025 11:39 AM

More from Storyboard18